Navigation Links
New research initiative investigates gene regulation in evolution and development
Date:4/2/2014

Johannes Gutenberg University Mainz (JGU) has received EUR 900,000 for three years to investigate, jointly with the Institute of Molecular Biology (IMB), how gene regulation affects evolution and development. The ambitious new research initiative GeneRED, or Gene Regulation in Evolution and Development, is jointly run by IMB and JGU's Faculty of Biology, funded by the Ministry of Education, Science, Continuing Education, and Culture of Rhineland-Palatinate. Its overarching goal is to gain insight into how epigenetics, i.e., the regulation of genes by elements outside the classical DNA code, can influence the development of organisms, both in the short term (growth and aging) and the long term (evolutionary adaptation).

The initiative aims to significantly strengthen research into gene regulation on the campus of Johannes Gutenberg University Mainz. To achieve this, it will fund six PhD positions at JGU's Faculty of Biology over three years (2014-2016). The questions these students are studying are:

  • How did division of labor evolve in social insects like ants, and which genes are involved?
  • How does the NURF complex help maintain neural stem cell identity in fruit flies?
  • What are the targets of the NG2 protein in glial cell development and tumors?
  • How do ciliary proteins affect DNA damage response and gene regulation in Usher syndrome?
  • What are the roles of genetic regulatory elements in the modern human adaptation to an agriculturalist diet and predisposition to metabolic syndrome?
  • Which epigenetic factors are involved in creating body size memory in fruit flies?

The participating PhD students will be fully integrated into the International PhD Program on "Dynamics of Gene Regulation, Epigenetics and DNA Damage Response," a joint program coordinated by IMB with groups from IMB, JGU, the Mainz University Medical Center, and the Max Planck Institute for Polymer Research.

The initiative will also help expand access to modern proteomics technologies for scientists at JGU and IMB. With proteomics becoming a key methodology in modern biomedical research, the support provided through this initiative will be crucial in ensuring that research in Mainz is internationally competitive.

The chairs of the GeneRED project are Hans Zischler, Dean of the Faculty of Biology at JGU, and Christof Niehrs, Founding and Executive Director of IMB. The General Manager of GeneRED is Ralf Dahm, IMB's Director of Scientific Management.


'/>"/>

Contact: Dr. Ralf Dahm
press@imb-mainz.de
49-613-139-21450
Johannes Gutenberg Universitaet Mainz
Source:Eurekalert

Related biology news :

1. Research method integrates meditation, science
2. Global research possibilities expand as IISD assumes operation of Canadas famed Experimental Lakes
3. UCLA scientist awarded $3 million to fund research into proteins affecting the kidney
4. Cfaed starts a research project on organic electronics with the University of Brasília
5. Researchers reveal a new pathway through the sodium pump
6. Researchers uncover secrets of a mollusks unique bioceramic armor
7. Scripps Florida scientists offer best practices nutrition measurement for researchers
8. Researchers identify new protein markers that may improve understanding of heart disease
9. Research clarifies health costs of air pollution from agriculture
10. Two researchers known for identifying and treating bubble boy disease honored by March of Dimes
11. Research center to develop next generation of advanced chemical products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/3/2017)... 2017 A new independent identity strategy consultancy ... (IdSP) . Designed to fill a critical niche in ... founding partners Mark Crego and Janice ... in identity expertise that span federal governments, the 9/11 ... Crego-Kephart combined expertise has a common theme born from ...
(Date:2/2/2017)... Feb. 1, 2017  Central to its deep ... advances worldwide, The Japan Prize Foundation today announced ... have pushed the envelope in their respective fields ... Three scientists are being recognized with the 2017 ... not only contribute to the advancement of science ...
(Date:1/30/2017)... , Jan. 30, 2017   Invitae Corporation ... growing genetic information companies, today announced that it will ... and provide 2017 guidance on Monday, February 13, 2017, ... that day at 4:45 p.m. Eastern / 1:45 p.m. ... team will briefly review financial results, guidance, and recent ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... ... 2017 , ... Delpor, Inc. (Delpor), a biotechnology company focused on drug delivery, ... Health (NIMH) for the further advancement of the company’s 3-month olanzapine product ( DLP-119 ... to deliver therapeutic levels of olanzapine for a period of 3 months., “We are ...
(Date:2/24/2017)... , Feb. 24, 2017 Provectus ... or the "Company"), a clinical-stage oncology and dermatology ... the deadline to participate in its previously announced ... consisting of shares of common stock and Series ... holders of listed warrants. As ...
(Date:2/24/2017)... Feb. 24, 2017 Symic Bio, a biopharmaceutical ... new category of therapeutics, announced today the completion of ... peripheral artery disease. The trial will evaluate the safety ... in the reduction of restenosis following angioplasty. ... milestone for SB-030," said Nathan Bachtell , M.D., ...
(Date:2/24/2017)... KONG, Feb. 24, 2017 China Cord Blood Corporation ... China,s leading provider of cord blood collection, laboratory testing, ... today announced its unaudited financial results for the third ... ended December 31, 2016. Third Quarter of ... third quarter of fiscal 2017 increased by 18.6% to ...
Breaking Biology Technology: